[Available methods to modify primary graft rejection (author's transl)].
Primary graft rejection is an immunological reaction. Many modes of preventing, or at least, delaying rejection have already been tested. The present study deals with experiences and possible mechanisms of action of nonspecific immunosuppression caused by different drugs or antilymphocytic sera; furthermore, an account is given of the latest stand of knowledge gained from experimental studies to induce immunological enhancement, as well as immunological tolerance to transplantation antigens.
D000818:Animals; D000906:Antibodies; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000494:pharmacology; D006084:Graft Rejection / Q000187:drug effects*; D006680:HLA Antigens / Q000302:isolation & purification; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology
D000906:Antibodies; D000961:Antilymphocyte Serum; D006680:HLA Antigens; D007166:Immunosuppressive Agents
Möglichkeiten zur Beeinflussung der primären Transplantatabstossung.